Risk Management



3rd Edition of “ROP: Creating a Safety Net” Published

OMIC ROP Safety Net revised in 2022 to reflect changes to International Classification of Retinopathy of Prematurity, Third Edition (ICROP3). In 2023 we added Telemedicine Protocols and Recommendations. 

Click on the name of the document to access it. 

Clinical Tables Revised with Changes Highlighted

ROP Risk Analysis 

ROP Conditions of Coverage

ROP Risk Management Recommendations for AntiVEGF

ROP Tracking List

HOSPITAL ROP TOOLKITS

Hospital toolkit.Treat at hospital

Hospital toolkit.Transfer to treat

OFFICE ROP TOOLKIT

The Office toolkit has additional procedures, forms, and letters needed for outpatient care.

FORMS AND LETTERS

The following consent forms and letters are in the toolkits and procedures, but can also be accessed directly:

Consent: ROP Injection to Treat 

Consent: ROP Laser Surgery to Treat 

ROP-Remote-Digital-Fundus-Imaging-Telemedicine-Consent

Discharge letter

Missed appointment letter

Outpatient screening letter

Transfer for other care letter

Transfer to treat

ROP Protocol and Recommendations for Telemedicine

ROP Telemedicine 9.16.23

 

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment



Six reasons OMIC is the best choice for ophthalmologists in America.

Consistent return of premium.

Publicly-traded insurance companies exist to make profits for shareholders while physician-owned carriers often return profits to their policyholders. Don’t underestimate this benefit; it can add up to tens of thousands of dollars over the course of your career. OMIC has one of the most generous dividend programs for ophthalmologists and has returned more than $90 Million to our members through dividends.

61864684